Semler Scientific Reports Impressive Preliminary Q4 2024 Results
Today, Semler Scientific, Inc. (NASDAQ: SMLR), a leading tech company in healthcare, disclosed its preliminary unaudited financial results for the fourth quarter of 2024. Semler, known for its innovative technology products focused on chronic diseases, is gearing up to share its full financial outcomes by the end of February. This release highlights notable revenue, income, and significant unrealized gains from Bitcoin investments.
Financial Highlights of Q4 2024
For the fourth quarter, Semler Scientific reported revenues ranging between $12.1 million and $12.5 million. Furthermore, the company’s income from operations stood between $3.4 million and $3.7 million. Among their notable achievements was an unrealized gain attributed to their Bitcoin holdings, estimated at around $28.9 million, showcasing their strategic investment decisions.
Cash Reserves and Financial Positioning
As of December 31, 2024, Semler Scientific retained cash, restricted cash, and cash equivalents totaling approximately $9.0 million. This robust financial positioning signifies the company's ability to support ongoing operations and strategic growth initiatives.
Comments from Leadership
Doug Murphy-Chutorian, M.D., the CEO of Semler Scientific, expressed satisfaction with these preliminary figures, stating, "We are pleased to report these preliminary unaudited numbers and significant unrealized gain from our Bitcoin holdings. We are excited to continue executing on our Bitcoin treasury strategy." This statement emphasizes the company’s confidence in its forward direction amidst a volatile market.
Bitcoin Holdings Overview
As of January 17, 2025, Semler Scientific possesses a total of 2,321 bitcoins, purchased for a cumulative amount of $191.9 million. With an average acquisition cost of $82,689 per Bitcoin, inclusive of all fees, their Bitcoin treasury strategy demonstrates a significant commitment to cryptocurrencies as part of their asset management approach.
Upcoming Conference Call
Semler Scientific plans to hold a conference call on February 18, 2025, following the release of their complete financial results for Q4 2024. Dr. Murphy-Chutorian will lead this session joined by other key executives including Eric Semler and Renae Cormier. This call will provide a platform for detailed discussions regarding their financial performance and ongoing strategies in cryptocurrency investments.
About Semler Scientific, Inc.
Founded with a mission to innovate in the healthcare sector, Semler Scientific, Inc. focuses on developing and marketing advanced technology aimed at addressing chronic diseases. Their primary product, QuantaFlo®, is a rapid point-of-care test authorized by the U.S. FDA that assesses arterial blood flow in extremities, assisting healthcare professionals in diagnosing serious cardiovascular conditions, such as peripheral arterial disease. Semler is seeking additional regulatory clearances for expanded uses of their technology while positioning itself as a forward-thinker in cryptocurrency as a treasury asset.
Frequently Asked Questions
What are the key financial results reported by Semler Scientific?
The company reported revenues between $12.1 million and $12.5 million, with an operational income ranging from $3.4 million to $3.7 million for Q4 2024.
What significant gain did Semler Scientific achieve?
Semler Scientific achieved approximately $28.9 million in unrealized gains from their Bitcoin holdings, reflecting their strategic investment decisions in cryptocurrency.
When will Semler Scientific release its full financial results?
The complete financial results for Q4 2024 will be reported on February 18, 2025, after U.S. market close.
How many bitcoins does Semler Scientific hold?
As of January 17, 2025, Semler Scientific holds 2,321 bitcoins, acquired for around $191.9 million.
Who will lead the upcoming conference call?
Dr. Doug Murphy-Chutorian, CEO of Semler Scientific, will lead the conference call, joined by other key executives including Renae Cormier and Eric Semler.
